FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KORFF, T.
Right arrow Articles by AUGUSTIN, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KORFF, T.
Right arrow Articles by AUGUSTIN, H. G.
(The FASEB Journal. 2001;15:447-457.)
© 2001 FASEB

Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness

THOMAS KORFF, SARAH KIMMINA, GEORG MARTINY-BARON* and HELLMUT G. AUGUSTIN1

Cell Biology Laboratory, Department of Gynecology and Obstetrics, University of Göttingen Medical School, 37075 Göttingen; and
* Institute of Molecular Medicine, Tumor Biology Center, 79106 Freiburg, Germany

1Correspondence: Institute of Molecular Medicine, Tumor Biology Center, D-79106 Freiburg, Germany. E-mail: augustin{at}angiogenese.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Paracrine interactions between endothelial cells (EC) and mural cells act as critical regulators of vessel wall assembly, vessel maturation and define a plasticity window for vascular remodeling. The present study was aimed at studying blood vessel maturation processes in a novel 3-dimensional spheroidal coculture system of EC and smooth muscle cells (SMC). Coculture spheroids differentiate spontaneously in a calcium-dependent manner to organize into a core of SMC and a surface layer of EC, thus mimicking the physiological assembly of blood vessels with surface lining EC and underlying mural cells. Coculture of EC with SMC induces a mature, quiescent EC phenotype as evidenced by 1) a significant increase in the number of junctional complexes of the EC surface layer, 2) a down-regulation of PDGF-B expression by cocultured EC, and 3) an increased resistance of EC to undergo apoptosis. Furthermore, EC cocultured with SMC become refractory to stimulation with VEGF (lack of CD34 expression on VEGF stimulation; inability to form capillary-like sprouts in a VEGF-dependent manner in a 3-dimensional in gel angiogenesis assay). In contrast, costimulation with VEGF and Ang-2 induced sprouting angiogenesis originating from coculture spheroids consistent with a model of Ang-2-mediated vessel destabilization resulting in VEGF responsiveness. Ang-2 on its own was able to stimulate endothelial cells in the absence of Ang-1 producing SMC, inducing lateral sheet migration as well as in gel sprouting angiogenesis. Taken together, the data establish the spheroidal EC/SMC system as a powerful cell culture model to study paracrine interactions in the vessel wall and provide functional evidence for smooth muscle cell-mediated quiescence effects on endothelial cells.—Korff, T., Kimmina, S., Martiny-Baron, G., Augustin, H. G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.


Key Words: EC • SMC • spheroid • vascular endothelial growth factor


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
RECENT ADVANCES in the analysis of the mechanisms of vascular morphogenesis as they are associated with vasculogenesis, angiogenesis, intussuseption, and arteriogenesis have heightened interest in the mechanisms of vessel assembly and maturation and the cellular interactions that control these processes. Platelet-derived growth factor B (PDGF-B) -deficient mice are characterized by an inability to recruit pericyte progenitor cells in a subset of blood vessels and thus are not able to assemble a mature vasculature in several organs including brain, heart, lung, and brown adipose tissue (1) . Correspondingly, exogenous PDGF-B has been shown to promote pericyte recruitment to the immature retina vasculature of newborn rats (2) . These experiments also demonstrated that mural cells stabilize the immature neovasculature, rendering endothelial cells (EC) independent of the activities of survival factors such as vascular endothelial growth factor (VEGF) and limiting the plasticity window that allows remodeling and pruning of a newly formed vascular bed (2 , 3) . Another receptor/ligand system involved in vessel assembly and maturation is the Tie-2/angiopoietin system (4 , 5) . The ligand for the receptor tyrosine kinase Tie-2 angiopoietin 1 (Ang-1) has been identified as an endothelial cell specific growth factor that is proangiogenic, acts as an endothelial cell survival factor, and promotes stabilization of blood vessels through endothelial cell contacts with mural cells (6 7 8) . Ang-1 reduces vascular permeability even in the presence of the proangiogenic and permeability-promoting cytokine VEGF (9) . Ang-2 has been characterized as a competitive functional antagonist of Ang-2 that binds Tie-2 without transducing an activating signal (10) . As a consequence, Ang-2 is believed to act as a vessel-destabilizing agent that either induces vessel regression (in the absence of proangiogenic activity) or facilitates angiogenesis (in the presence of proangiogenic activity) (4 , 5) .

Most recent findings on the functions of molecules that play critical roles in the process of vascular morphogenesis have been generated through genetic manipulation experiments in mice by either specifically deleting the function of a candidate gene (loss of function) or by transgenically overexpressing a gene of interest (gain of function). As sophisticated as these experimental strategies are, the early embryonic lethality of mice with targeted mutations of genes that are critical for vascular morphogenetic events greatly reduces examination of the resulting phenotypes to morphological analyses and limits detailed mechanistic experiments.

Mechanistic experiments on specific endothelial cell functions have been performed in great detail using monolayer cell culture techniques on plastic substrata or components of the extracellular matrix. These studies have contributed to understanding the complexity of the vascular endothelium. Great progress has been made in identifying molecular determinants of activated endothelial cells as they are expressed during inflammation, atherosclerosis, or angiogenesis (11 12 13) . However, the reductionist approach of standard monolayer cell culture strategies and the inherent dedifferentiation of primary cultures of endothelial cells have largely precluded in vitro studies of complex endothelial cell functions as they are associated with vessel assembly, maturation, and organotypic as well as caliber-specific differentiation. We have recently developed a 3-dimensional spheroidal system of endothelial cell differentiation (14) and in vitro angiogenesis (15) . Based on the unique properties of this model, we hypothesized it might be possible to further develop this cell culture system toward a proper in vitro representation of the 3-dimensional assembly of a normal blood vessel. Consequently, we devised experiments aimed at establishing organized coculture spheroids of endothelial cells and smooth muscle cells (SMC) with a luminal aspect, a polarized endothelial cell monolayer, and an underlying multilayered assembly of smooth muscle cells. After developing a model that fulfills these requirements, we pursued experiments to study paracrine interactions between endothelial cells and smooth muscle cells that control the quiescent phenotype of endothelial cell and regulate the functions of angiogenic cytokines.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Antibodies, growth factors, and reagents
Fibroblast growth factor 2 (FGF-2) was obtained from Promega (Mannheim, Germany). Human recombinant angiopoietin-2 and human recombinant VEGF were obtained from R&D Systems GmbH (Wiesbaden, Germany). Recombinant human soluble Tie-2 receptor Fc fusion protein (sTie-2-Fc) (amino acids 1 [Met] through 730 [Val]) was expressed in baculovirus and propagated in Spodoptera frugiperda cells (Sf9). Recombinant protein was purified by protein A Sepharose columns. Carboxymethylcellulose (4,000 centipoises) and the fluorescent dyes PKH26 and PKH67 were from Sigma (Deisenhofen, Germany). Neutralizing (type I) monoclonal mouse anti-bovine FGF-2 antibody was purchased from Upstate Biotechnology (Biomol, Hamburg, Germany). The monoclonal mouse anti-CD34 antibody (clone QBEnd/10) was purchased from Novocastra Laboratories (Loxo GmbH, Dossenheim, Germany) and the monoclonal mouse anti-CD31 antibody was obtained from DAKO (Glostrup, Denmark). The polyclonal rabbit anti-PDGF-B antibody was from Biogenex (San Ramon, Calif.).

Cell culture
Endothelial cell growth medium (ECGM), endothelial cell growth supplement (human umbilical vein endothelial cell culture), and human smooth muscle cell growth medium (HSMCGM) were purchased from Promocell (Heidelberg, Germany). Fetal calf serum (FCS) was obtained from Biochrom (Berlin, Germany). Human umbilical vein endothelial cells (HUVEC) were freshly isolated from human umbilical veins of newborn babies by collagenase digestion. Cells were cultured at 37°C in 100 mm tissue culture dishes in ECGM containing 10% heat-inactivated fetal calf serum and frozen in liquid nitrogen at passage 2 or 3. Only HUVE cells cultured from passage 4 to 8 were used for experiments. Human umbilical artery smooth muscle cells were purchased from Promocell and cultured in HSMCGM at 37°C in 100 mm tissue culture dishes up to passage 9.

Generation of endothelial cell, smooth muscle cell, and coculture spheroids
Endothelial cell and smooth muscle cell spheroids of defined cell number were generated as described previously (14) . In brief, SM or HUVE cells were suspended in corresponding culture medium containing 0.25% (w/v) carboxymethylcellulose and seeded in nonadherent round-bottom 96-well plates (Greiner, Frickenhausen, Germany). Under these conditions, all suspended cells contribute to the formation of a single spheroid per well of defined size and cell number (standard size: 2250 cells/spheroid; in vitro angiogenesis: 750-1000 cells/spheroid). To generate coculture spheroids, equal amounts of suspended SM and HUVE cells (standard size: 1125 SMC and 1125 HUVEC per spheroid; in vitro angiogenesis: 500 SMC and 500 HUVEC per spheroid) were mixed and seeded in nonadherent round-bottom 96-well plates as described above. Spheroids were cultured for at least 24 h and used for the corresponding experiments.

In vitro angiogenesis assay
In vitro angiogenesis in collagen gels was quantitated using endothelial cell, smooth muscle cell, and coculture spheroids as described previously (15) . In brief, spheroids containing 750-1000 cells were generated overnight, after which they were embedded into collagen gels. A collagen stock solution was prepared prior to use by mixing 8 vol acidic collagen extract of rat tails (equilibrated to 2 mg/ml, 4°C) with 1 vol 10x EBSS (Gibco BRL, Eggenstein, Germany); ~ 1 vol 0.1 N NaOH to adjust the pH to 7.4. This stock solution (0.5 ml) was mixed with 0.5 ml room temperature medium (ECGM basal medium [PromoCell] with 40% FCS [Biochrom, Berlin, Germany]) containing 0.5% (w/v) carboxymethylcellulose to prevent sedimentation of spheroids prior to polymerization of the collagen gel, 50 spheroids, and the corresponding test substance. The spheroid containing gel was rapidly transferred into prewarmed 24-well plates and allowed to polymerize (1 min), after which 0.1 ml ECGM basal medium was pipetted on top of the gel. The gels were incubated at 37°C, 5% CO2, and 100% humidity. After 24 h, in vitro angiogenesis was digitally quantitated by measuring the length of the sprouts that had grown out of each spheroid (ocular grid at 100x magnification) using the digital imaging software DP-Soft (Olympus, Germany) analyzing at least 10 spheroids per experimental group and experiment.

Fluorescent cell labeling
SMC and HUVEC were labeled using the fluorescent dyes PKH26 (red fluorescence) and PKH67 (green fluorescence) following manufacturer’s instructions. After trypsinization, suspended cells were washed once with HBSS, membrane labeled with PKH26 or PKH67 for 5 min, and washed three times using corresponding culture medium. Quality of cell labeling was examined using fluorescence microscopy.

Ultrastructural analysis
Spheroids were fixed in Karnovsky’s fixative, postfixed in 1.0% osmium tetroxide, dehydrated in a graded series of ethanol, and embedded in Epon. Sections of 0.5 µm were cut and stained with azure 11 methylene blue for light microscopic evaluation. Ultrathin sections (50–80 nm) were cut, collected on copper grids, and automatically stained with uranyl acetate and lead citrate for observation with a Zeiss EM 10 electron microscope.

For quantitation of interendothelial junctional complexes in surface spheroid endothelial cells, all junctional complexes of 20 randomly selected spheroids per experimental group in two independent preparations were counted. Results were expressed as the number of junctional complexes per 100 surface monolayer endothelial cells (analysis of at least 200 EC per experimental group).

Morphological and immunohistochemical analysis
Spheroids were harvested and centrifuged for 3 min at 200 g. Cultured monolayer cells were harvested by trypsinization and collected by centrifugation. Spheroids and pelleted monolayer cells were fixed in HBSS containing 4% paraformaldehyde and processed for paraffin embedding; after dehydration (graded series of ethanol and isopropanol, 1 h each), the specimens were first immersed with paraffin I (melting temperature 42°C) for 12 h at 60°C. Spheroids and monolayer cells were again collected by centrifugation and immersed with paraffin II (melting temperature 56°C) for 12 h at 70°C. Finally, the resulting paraffin block was cooled to room temperature and trimmed for sectioning. For histochemical analyses, paraffin sections (4 µm) were cut, deparaffinized, and rehydrated. Sections were then incubated with 3% H2O2 in H2O to inhibit endogenous peroxidase. After washings in phosphate-buffered saline, the sections were incubated for 30 min with blocking solution (10% normal goat serum), followed by incubation with the corresponding primary antibody in a humid chamber at 4°C overnight. Then they were incubated with secondary antibody (biotinylated goat anti-rabbit immunoglobulin or biotinylated goat anti-mouse immunoglobulin antibody; Zymed, San Francisco, Calif.), exposed to streptavidin peroxidase, developed with diaminobenzidine as substrate, and weakly counterstained with hematoxylin.

Detection of apoptotic cells in spheroids
Apoptotic cells were visualized by histochemical detection of nucleosomal fragmentation products (TUNEL) applying the In Situ Cell Death Detection Kit (Boehringer Mannheim, Germany) following the manufacturer’s instructions. In brief, nucleosomal fragmentation products in sections of paraffin-embedded spheroids were detected after deparaffination and proteinase K digestion by 3' end labeling with fluorescein-dUTP using terminal deoxynucleotidyl transferase. Labeling was visualized either directly by fluorescence microscopy or indirectly after incubating the sections with peroxidase-labeled anti-fluorescein antibody and developing with diaminobenzidine as substrate.

DNA fragmentation enzyme-linked immunoassay (ELISA)
Quantitation of fragmented DNA was performed by ELISA (Cell Death Detection ELISA Kit; Boehringer Mannheim, Germany). Fragmented DNA of 10 spheroids was extracted by lysis for 60 min at room temperature with vigorous shaking. The extracts were centrifuged for 10 min at 13,000 g and 300 µl of the supernatant was incubated with peroxidase-labeled anti-DNA antibody and biotinylated anti-histone antibody in streptavidin-coated microtiter plates following the manufacturer’s instructions. After washing, binding of mono- and oligonucleosomal DNA was visualized by developing with the peroxidase substrate ABTS (2,2'-azino-di[3-ethylbenzthiazolin-sulfonate]). Plates were analyzed at 405 nm using an automated microtiter plate reader (EAR 400AT, SLT Lab instruments, Austria).

Statistical analysis
All results are expressed as mean ± SD. Differences between experimental groups were analyzed by unpaired Student’s t test. P values <0.05 were considered statistically significant.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Coculture spheroids of EC and SMC form spontaneously and differentiate over time in a calcium-dependent manner
Modifying the recently established endothelial cell spheroid differentiation model (14) , we developed a spheroidal coculture system of endothelial cells and smooth muscle cells aiming at mimicking the correct 3-dimensional assembly of the normal vessel wall. Equal numbers of human umbilical vein EC and human umbilical artery SMC were mixed and suspended in nonadhesive 96-well round-bottom plates in methocel containing medium. Essentially all of the cells in one well sediment and contribute to the formation of a single cellular aggregate, which was found to spontaneously organize into a core of SMC and a surface layer of EC. Differentiation of the coculture spheroids was traced by staining endothelial cells for CD31 expression (Fig. 1 ). Complementary results were obtained by staining SMC for the expression of {alpha}-smooth muscle actin. Solo EC spheroids stained uniformly for CD31 with the surface EC stained more intense than the center EC (Fig. 1A ). In contrast, solo SMC spheroids did not stain for CD31 (Fig. 1B ). Coculture spheroids of EC and SMC differentiate within 2 days to establish a core of SMC and a surface layer of EC (Fig. 1C ). The surface layer differentiates over time to form a flat monolayer of cells within 4 days (Fig. 1D ). Thus, coculture spheroids of EC and SMC differentiate in a way that resembles the 3-dimensional organization of the normal vessel wall in an inside-out orientation of luminal side (medium), endothelial cell lining, and multilayered SMC core. This compartmental organization was found to be calcium dependent. When coculture spheroids were allowed to establish for 24 h and then treated with EGTA for another 24 h, spheroidal organization was found to be completely disrupted, with EC and SMC evenly distributed within the spheroid (Fig. 1E ). Likewise, when different endothelial cell populations were mixed (HUVEC and murine endothelioma cells BEND), the cells did not mix and formed clustered aggregates of individual cell populations, demonstrating the specificity of the morphogenetic interactions that occur in EC/SMC coculture spheroids (Fig. 1F ).



View larger version (97K):
[in this window]
[in a new window]
 
Figure 1. Spontaneous differentiation of coculture spheroids of human umbilical vein endothelial cells (EC) and human umbilical artery smooth muscle cells (SMC). EC spheroids (A), SMC (B), and EC/SMC coculture spheroids (C–F) were cultured for various periods of time, after which they were fixed, embedded, sectioned, and stained for expression of the endothelial cell marker CD31. A) Section of a 2 day EC spheroid uniformly stained for CD31. B) SMC in spheroids (2 days) do not express CD31. C) EC/SMC coculture spheroid (2 days) with CD31 positive surface layer of EC and core of CD31 negative SMC. Few single CD31 positive EC are trapped in the center of the spheroid. D) EC/SMC coculture spheroid (4 days) with CD31 positive surface layer of EC and core of CD31 negative SMC (note the flattened EC monolayer in 4 day coculture spheroids compared to 2 day coculture spheroids as shown in panel C). E) The organization of EC/SMC coculture spheroids is calcium dependent. Addition of EGTA (5 mM) for 24 h into 1 day coculture spheroids disrupts their compartmental organization and causes an even distribution of CD31 positive EC and CD31 negative SMC. F) HUVE cells cocultured with BEND cells (murine endothelioma cells) segregate from each other and do not form mixed coculture spheroids (HUVEC stained for CD31 with anti-human-CD31 antibody [arrow]; mouse EC do not stain with this antibody). Scale bar in panel E: 50 µm.

Formation of interendothelial junctional complexes is enhanced in EC/SMC coculture spheroids
Based on the observed spontaneous organization of coculture spheroids of EC and SMC, we next asked whether SMC in coculture spheroids control phenotypic properties of the surface endothelial cell layer. Sections of EC spheroids and EC/SMC coculture spheroids cultured for 1 and 4 days were examined ultrastructurally and the number of interendothelial electron dense junctional complexes was quantitated (Fig. 2 ). The number of interendothelial cell junctional complexes of the surface endothelial cell monolayer increased over time in both solo EC spheroids and EC/SMC coculture spheroids. Endothelial cells in coculture spheroids, however, established more than twice as many junctional complexes after 4 days as solo EC spheroids (P<0.05; Fig. 2A ).



View larger version (60K):
[in this window]
[in a new window]
 
Figure 2. Quantitative analysis of electron dense junctional complexes in the surface EC layer of EC spheroids and EC/SMC coculture spheroids. A) The number of interendothelial electron dense junctional complexes (as shown in panel B) was counted in 1- and 4-day-old EC spheroids and EC/SMC coculture spheroids. The surface EC monolayer of coculture spheroids establishes significantly more junctional complexes than EC spheroids without SMC (P<0.01).

Endothelial PDGF-B expression is completely down-regulated in EC/SMC coculture spheroids over time
EC cultured as monolayers express abundant levels of PDGF-B under various culture conditions, which has repeatedly been interpreted to reflect the inability to properly mimic the in vivo quiescent EC phenotype in tissue culture (16 , 17) . Corresponding in vivo experiments have demonstrated that endothelial cell PDGF-B expression is restricted to immature capillary endothelial cells and to the endothelium of growing arteries (18) . We consequently analyzed PDGF-B expression in monolayer EC and in spheroids of EC and SMC, applying histochemical techniques in order to identify the PDGF-B expressing cells. Sections of embedded confluent and subconfluent monolayers of EC expressed very high levels of PDGF-B (Fig. 3A , B ). Similarly, EC cultured in solo EC spheroids diffusely express abundant amounts of PDGF-B after 1 or 4 days in culture (Fig. 3C , D ). SMC in spheroids do not express PDGF-B (Fig. 3E , F ). Coculture spheroids of EC and SMC have detectable levels of PDGF-B in their center as well as in the surface monolayer after 1 day in culture (Fig. 3G ). No PDGF-B expression is detectable in EC/SMC coculture spheroids after 4 days. The surface monolayer of EC, which is in contact with the underlying EC, becomes completely PDGF-B negative in these coculture spheroids (Fig. 3H ). Histochemical analysis of PDGF-B expression in solo and coculture spheroids was complemented by ELISA quantitation of PDGF-B protein in the supernatants of 4 day solo and coculture spheroids. Significant levels of PDGF-B protein were detected in the supernatant of solo EC spheroids. In contrast, PDGF-B protein concentrations were beyond detection level in the supernatants of SMC spheroids as well as EC/SMC-coculture spheroids (data not shown), confirming the histochemically determined down-regulation of EC PDGF-B synthesis in coculture with SMC.



View larger version (98K):
[in this window]
[in a new window]
 
Figure 3. Immunohistochemical analysis of PDGF-B expression in paraffin-embedded and sectioned subconfluent (A) and confluent (B) monolayer, EC spheroids (C, 1d; D, 4d), SMC spheroids (E, 1d; F, 4d), and EC/SMC coculture spheroids (G, 1d; H, 4d). Monolayer EC as well as EC in spheroids express abundant levels of PDGF-B. Cells in SMC spheroids do not express PDGF-B. Moderate levels of PDGF-B are detected in 1 day EC/SMC coculture spheroids in the center and surface EC. No expression of PDGF-B is detectable in the surface EC layer of mature 4 day EC/SMC coculture spheroids (D vs. H).

Coculture of EC and SMC in spheroids inhibits EC apoptosis induced by serum starvation
Contact of endothelial cells with mural cells (pericytes, smooth muscle cells) has been shown to limit a plasticity window for vessel remodeling and to render endothelial cells independent of the activities of survival factors such as VEGF, FGF-2, or Ang-1 (2 , 19) . We consequently analyzed whether EC apoptosis is affected by the presence of SMC in EC/SMC coculture spheroids. Solo EC and SMC spheroids as well as EC/SMC coculture spheroids were cultured for 2 days under low serum conditions. Under these conditions, EC in solo EC spheroids undergo massive apoptosis, as evidenced by DNA fragmentation ELISA measuring the amount of fragmented DNA of 10 individual spheroids (EC control set as 100%; Fig. 4A , B ). Treatment of EC spheroids with EGTA (disruption of Ca-dependent cell–cell contacts) or anti-FGF-2 antibody (inhibition of endogenous FGF-2) increased the level of EC beyond the linear scale of the apoptosis ELISA (comparison of ELISA and TUNEL; Fig. 4A , B , E ). Likewise, treatment of EC spheroids with FGF-2 decreased the level of apoptosis significantly by ~50% (P<0.005, Fig. 4A ). In contrast, SMC cultured in spheroids have very low baseline levels of apoptosis that are barely influenced by exposure to EGTA, FGF-2, or {alpha}-FGF-2 (Fig. 4A , C , F ). Cocultures of equal numbers of EC and SMC had significantly lower levels of apoptosis as the calculated mean of solo EC and SMC spheroids (EC: 100%, SMC: 8%, EC/SMC calculated: 54%; EC/SMC observed: 18%; Fig. 3A , D ). Treatment of coculture spheroids with EGTA increased the observed level of apoptosis toward the calculated level (Fig. 3A , G ). Together, these findings strongly suggest that the presence of SMC in the coculture spheroids stabilizes EC to reduce the levels of EC apoptosis, although it must be realized that EC have very different growth configurations in solo and coculture spheroids, which may also affect EC apoptosis.



View larger version (66K):
[in this window]
[in a new window]
 
Figure 4. Quantitative (A, ELISA) and qualitative (B–G, TUNEL) analysis of apoptosis in EC spheroids (A, black bars), SMC spheroids (A, open bars), and EC/SMC coculture spheroids (A, stippled bars). A) Spheroids were cultured for 24 h under low serum conditions (2% FCS), after which the test substances were added (EGTA: 5 mM; FGF-2: 30 ng/ml; neutralizing FGF-2 antibody: 4 µg/ml). Treated spheroids were cultured for another 24 h and nucleosomal fragmentation products were quantitated by ELISA. The level of nucleosomal fragmentation of untreated EC spheroids was set to 100%, which was still in the linear range of the ELISA. The figure shows the mean ± SD of three independent experiments performed in duplicate. B–G) TUNEL staining of untreated (B–D) and EGTA-treated (E–G) spheroids. Apoptosis in EC/SMC coculture spheroids is reduced to less than the mean of the level in solo EC spheroids and solo SMC spheroids. EGTA treatment disrupts EC but no SMC organization leading to elevated levels of apoptosis in EC and EC/SMC coculture spheroids.

EC/SMC contacts in coculture spheroids inhibit VEGF-induced endothelial CD34 expression
Most EC in vivo express the cell surface glycoprotein CD34 (20 , 21) . Upon transfer of EC in tissue culture, however, CD34 is rapidly down-regulated (22) . We have recently shown that VEGF selectively stimulates the surface EC in 3D spheroids to reexpress CD34 (14) . Based on these findings, we analyzed endothelial CD34 expression in EC and EC/SMC spheroids as a functional readout for VEGF-dependent activation of EC. Untreated EC cultured in spheroids do not express CD34 (Fig. 5A , B ). Treatment of EC spheroids with VEGF induces the surface EC to express CD34 (Fig. 5B ). This effect can be quantitated by counting the number of positive cells of the surface monolayer (Fig. 5A ). EC cocultured with SMC in spheroids do not express CD34 (Fig. 5A , C ) and cannot be induced to express CD34 by stimulation with VEGF (Fig. 5A , E ), suggesting that the surface layer of EC has become refractory to the stimulation with VEGF upon contact with SMC. To analyze whether cell–cell contacts between EC and SMC are involved in regulating EC responsiveness toward VEGF in the presence of SMC, we reduced the number of cellular contacts between EC and SMC by coculturing four times as many EC as SMC in coculture spheroids, which leads to the formation of a multilayered surface of EC. Stimulation of these 4:1 EC/SMC coculture spheroids with VEGF significantly induced surface EC to express CD34 compared to VEGF-treated 1:1 EC/SMC coculture spheroids (P<0.001; Fig. 5A ).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 5. Analysis of CD34 expression in surface spheroid EC as a readout of VEGF responsiveness. A) A quantitative analysis of CD34 expression was performed in 2 day spheroids by counting the number of CD34-positive surface EC in relation to the total number of surface EC. EC in solo EC spheroids do not express CD34 (A, B, CD34-negative EC spheroid with surface EC layer and apoptotic center). Stimulation of EC spheroids induces strong CD34 expression of the surface EC (A, C). Likewise, EC in EC/SMC coculture spheroids do not express CD34 (A, D). Stimulation of EC/SMC coculture spheroids with VEGF leads to CD34 expression in few surface EC (A, E). VEGF responsiveness can partially be restored by shifting the quantitative ratio of EC to SMC from 1:1 to 4:1 (A, P<0.01).

VEGF stimulation fails to induce sprouting of EC originating from collagen-embedded EC/SMC coculture spheroids
To further analyze the effects of SMC on EC effector functions and VEGF responsiveness, we performed experiments in gel angiogenesis with EC and EC/SMC spheroids. Spheroids were embedded in collagen gels and stimulated with VEGF. The cumulative length of outgrowing capillary-like sprouts was quantitated after 24 h (for unambiguous identification of cells, EC and SMC were labeled with different fluorescent dyes prior to the formation of coculture spheroids; see Materials and Methods).

VEGF acts as a potent inducer of sprouting angiogenesis originating from gel-embedded EC spheroids (~fourfold higher cumulative sprout length; P<0.001; Fig. 6A , B , F ). In contrast, VEGF stimulation of SMC embedded as spheroids did not induce sprouting of SMC into the collagen gel within 24 h (Fig. 6A , C , G ). There was no sprouting of cells from EC/SMC coculture spheroids (Fig. 6A , D ). Corresponding to the nonresponsiveness of EC in EC/SMC coculture spheroids in the CD34 induction experiments, VEGF had no effect on sprouting of EC into the collagen originating from EC/SMC coculture experiments (Fig. 6A , H ). However, when changing the ratio of EC to SMC to 4:1, we observed a significant induction of EC sprouting angiogenesis by VEGF originating from EC/SMC coculture spheroids (compared to 1:1 EC/SMC spheroids; P<0.001; Fig. 6A , E , I ).



View larger version (62K):
[in this window]
[in a new window]
 
Figure 6. 3-Dimensional in vitro angiogenesis with collagen gel-embedded spheroids of EC and SMC. Spheroids (1 day) were embedded into collagen gels with or without VEGF. The cumulative length of all the sprouts originating from an individual spheroid was quantitated after 24 h by semiautomatic image analysis. EC and SMC were labeled with fluorescent dyes to independently trace the sprouting of the two cell populations (EC, PKH26 [red fluorescence]; SMC; PKH67 [green fluorescence]). A) The mean ± SD of two independent experiments measuring the average cumulative sprout length of 10 individual spheroids per experimental group. Representatives of each experimental group are shown in panels B–I. EC spheroids (B) have a low baseline sprouting activity, which can be strongly stimulated by exogenous VEGF (50 ng/ml) (F). SMC originating from SMC spheroids have a low sprouting activity (C). The cells do not respond to VEGF (G). Likewise, there was no significant sprouting originating from EC/SMC coculture spheroids in the absence (D) or presence of VEGF (H). Shifting the ratio of EC to SMC from 1:1 to 4:1 restored some VEGF responsiveness (A, E, I, P<0.01).

Costimulation of collagen gel-embedded EC/SMC spheroids with Ang-2 and VEGF induces EC sprouting
Based on the observed nonresponsiveness of EC toward VEGF in EC/SMC coculture spheroids, we set out experiments aimed at restoring VEGF responsiveness of EC cocultured in the presence of SMC. These experiments led to costimulation in vitro angiogenesis experiments with VEGF and Ang-2. Ang-2 has been identified as a vessel-destabilizing cytokine that acts by functionally antagonizing Ang-1-mediated vessel maturation (5 , 10) . When applied individually, neither VEGF nor Ang-2 was able to induce EC sprouting originating from EC/SMC coculture spheroids (Fig. 7A , B , C , D , G , H , I ). However, costimulation of EC/SMC coculture spheroids with VEGF and Ang-2 induced EC sprouting (Fig. 7A , E , J ). PMA served as a positive control in these experiments, stimulating both EC as well as SMC outgrowth by directly stimulating protein kinase C (Fig. 7F vs. Fig. 7K ).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 7. Analysis of synergistic effects of VEGF and Ang-2 on EC sprouting originating from collagen gel-embedded EC/SMC coculture experiments. A) Quantitative analysis of 3 independent experiments quantitating the average cumulative sprout length of 10 spheroids per experimental group. B–F) Phase contrast images showing representatives of each experimental group. G–K) Fluorescent images of sprouts originating from EC/SMC coculture spheroids with PKH26-prelabeled EC to distinguish the two cell populations [F vs. K demonstrates EC and SMC sprouting (F) vs. EC sprouting (K)]. Little baseline EC sprouting originates from EC/SMC coculture spheroids (A, B, G). VEGF (50 ng/ml, A, C, H) and Ang-2 (up to 2 µg/ml, A, D, I) do not stimulate EC sprouting originating from EC/SMC coculture spheroids. Stimulation of coculture spheroids with both VEGF and Ang-2 induced significant sprouting of EC (P<0.001; A, E, J). PMA stimulation (0.5 µg/ml) served as positive control leading to EC sprouting as well as SMC sprouting (F vs. K). I) Quantitative analysis of the relative amounts of Ang-1 and Ang-2 mRNA using a quantitative coamplifying ratio RT-PCR (see Materials and Methods). EC spheroids express Ang-2. SMC spheroids express Ang-1. Correspondingly, 1:1 EC/SMC coculture spheroids express Ang-1 and Ang-2 at almost equimolar ratios. FGF-2 stimulation shifts the Ang-2/Ang-1 significantly toward Ang-2. VEGF does not affect relative Ang-1 and Ang-2 levels.

In line with the presumed function of Ang-2 as an Ang-1-antagonizing, vessel-destabilizing agent (5) , the observed synergistic effect of Ang-2 and VEGF on in vitro angiogenesis suggested that Ang-2 might act as a facilitator of VEGF function. We consequently analyzed the expression status of endogenous Ang-1 and Ang-2 in solo EC and SMC spheroids as well as in coculture spheroids. To assess relative ratios of Ang-1 and Ang-2, we used a quantitative coamplifying ratio reverse transcriptase-polymerase chain reaction (RT-PCR; ref 23 ). EC and SMC were found to express a complementary, non-overlapping pattern of angiopoietin production. EC in spheroids express Ang-2, whereas SMC in spheroids express Ang-1 (Fig. 7L ). Coculture spheroids (1:1) were found to express approximately equimolar ratios of Ang-1 and Ang-2 (densitometric Ang-2/Ang-1 ratio: 0.87±0.15; n=4). Stimulation of coculture spheroids with FGF-2 led to a significant shift of the Ang-2/Ang-1 ratio toward Ang-2 (2.36±0.19; P<0.001; n=4), corresponding to previously reported findings on the induction of Ang-2 by FGF-2 (26) . In contrast, addition of VEGF did not change the relative ratio of Ang-2 to Ang-1 mRNA (0.98±0.08; n=4), confirming the nonresponsiveness of EC/SMC coculture spheroids to VEGF stimulation.

Ang-2 stimulates endothelial cells in the absence of smooth muscle cells
Based on the observed synergism of Ang-2 and VEGF in mediating EC sprouting in the presence of Ang-1 expressing SMC, we next performed experiments to assess possible direct endotheliotropic functions of Ang-2 in the absence of SMC. We performed EC lateral sheet migration experiments (Fig. 8A ) and gel angiogenesis experiments using solo EC spheroids (Fig. 8B ). Surprisingly, both experimental approaches demonstrated that Ang-2 can directly stimulate EC in the absence of SMC, capable of dose-dependently stimulating EC migration and sprouting angiogenesis (Fig. 8) . Addition of sTie-2 completely blocked Ang-2-induced sprouting angiogenesis, confirming the specificity of Ang-2 induced endothelial cell activation.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 8. Analysis of direct stimulatory functions of Ang-2 in EC monolayers and EC spheroids cultured without SMC in collagen gels. A) Ang-2 stimulates lateral sheet migration of monolayer EC in a dose-dependent manner (250 ng/ml vs. control, P<0.05; four independent experiments performed in triplicates). B) Stimulation of sprouting angiogenesis originating from collagen-embedded EC spheroids. Ang-2 on its own is able to induce EC sprouting angiogenesis in a dose-dependent manner in a concentration range between 250 ng/ml and 1 µg/ml (P<0.001 for all experimental groups compared to control). Soluble Tie-2 (sTie-2) completely inhibits Ang-2 induced sprouting angiogenesis.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Bidirectional cross-talk between EC and SMC is a critical regulator of vascular homeostasis, contributing to the control vascular functions including vasotonus, coagulation, and the trafficking of circulating blood cells. Likewise, pathological changes in the cardiovascular system such as atherosclerosis and restenosis are associated with disturbed functional interactions between EC and SMC. To study paracrine interactions between EC and SMC in a defined in vitro model, the present study aimed to develop a coculture system of EC and SMC that mimics the physiological assembly of the normal vasculature so as to allow analysis of paracrine cellular interactions that regulate vessel assembly, maturation, maintenance, and vessel destabilization.

Numerous coculture systems of EC and SMC have been developed to study paracrine interactions in the vessel wall. These include planar coculture models of cells cultured together in the same dish, bilayer coculture, two-compartment filter systems, and agarose cocultures (16 , 17 , 25 26 27) . These studies have shown that EC and SMC regulate each other’s quiescent phenotype. EC-derived PDGF-BB controls mural cell recruitment and differentiation (1 , 26) . In turn, mural cell-derived, activated transforming growth factor ß (TGF-ß) contributes to the maintenance of the quiescent EC phenotype (28 , 29) .

Advancing a spheroidal EC cell culture system developed in our laboratory (14) , we have established in the present study a spheroidal coculture system of EC and SMC that is capable of mimicking the 3-dimensional assembly of a blood vessel with a luminal aspect, a polarized endothelial cell monolayer, and an underlying multilayered assembly of smooth muscle cells. These coculture spheroids can be regarded as an inside-out assembly of a resting vessel wall in which SMC control the quiescent phenotype of the EC monolayer. Organized EC/SMC coculture spheroids form within 2 days by simply pipetting them together in 96-well round-bottom dishes under nonadhesive conditions. The spontaneous differentiation of the coculture spheroids thus suggests a distinct morphogenetic interaction between EC and SMC to organize in a vessel wall like structure.

In analyzing the properties of the cells in the coculture spheroids and the interactions between the different cell types, we focused on SMC-mediated effects on the surface monolayer of EC. Several lines of experimental evidence demonstrated that SMC control the quiescent phenotype of EC through direct cell–cell contacts: 1) EC coculture in contact with SMC establish an increased number of interendothelial junctional complexes, 2) EC cocultured in spheroids with SMC down-regulate their expression of PDGF-B (16 , 17) , and 3) apoptosis of EC is reduced in coculture spheroids in the presence of SMC. Together, these findings suggest that the 3-dimensional assembly of EC and SMC mimics many of the physiological EC properties as they are expressed by the quiescent organ vasculature.

Given recent advances in the molecular mechanisms that control vessel assembly and maturation during vascular morphogenetic events (30 , 31) , we applied the EC/SMC coculture model to study effects of vascular morphogenetic cytokines on EC functional properties cocultured with SMC. We found that coculture of EC with SMC completely abrogated VEGF responsiveness, which was demonstrated by a lack of endothelial CD34 inducibility in the presence of SMC as well as an inhibition of sprouting angiogenesis in response to VEGF. The mechanism of SMC-mediated nonresponsiveness to VEGF is being investigated in our laboratory. Activation of latent TGF-ß has been shown to mediate some of the quiescence effects exerted by SMC on EC (28 , 29) . However, exogenous addition of TGF-ß resulted in partial inhibition of EC activation, but in none of our experiments was able to mediate nonresponsiveness to VEGF to an extent as direct coculture with SMC (data not shown). Recent experiments suggest that endothelial cell-derived PlGF is required for VEGF responses in the adult (32) . PlGF deficient mice have no apparent developmental or reproductive phenotype, but are not able to properly respond to VEGF (32) . The mechanism of this interaction has not been uncovered, but the interaction of PlGF and VEGF in mediating VEGF responsiveness suggests that VEGF responsiveness is probably not limited primarily by presentation of VEGF receptors.

Another cytokine that may be able to mediate VEGF responses is Ang-2. Ang-2 has been identified as a functional antagonist of the Tie-2 ligand Ang-1 (10) . Presumably, Ang-2 destabilizes interactions of EC with mural cells by competitively binding Tie-2 without transducing an activating signal. Correspondingly, Ang-2 functions are considered context dependent, either facilitating angiogenesis (in the presence of angiogenic activity) or inducing vessel regression (in the absence of angiogenic activity) (4 , 5) . Ang-2 is produced primarily by endothelial cells and thus seems to act as an autocrine regulator of vessel destabilization (24 , 33) . In line with the antagonistic model of Ang-2 function, costimulation of EC/SMC coculture spheroids with VEGF and Ang-2 led to the induction of sprouting angiogenesis in collagen gels, whereas neither VEGF nor Ang-2 was able to induce sprouting angiogenesis on its own. These findings demonstrate for the first time an in vitro function of Ang-2 on EC and can be interpreted as reflecting a facilitating role of Ang-2 for VEGF responsiveness in the presence of Ang-1-expressing SMC. When analyzing the effects of Ang-2 on solo EC populations, however, we made the puzzling observation that Ang-2 stimulates lateral sheet migration of EC as well as sprouting angiogenesis of gel-embedded EC spheroids. Collectively, these findings support a hypothetical model whereby Ang-2 function is context dependent in a way that it may act as an antagonistic molecule in the presence of Ang-1 and as an agonistic molecule in the absence of Ang-1. Experiments with the spheroidal EC/SMC model are now under way to test this hypothesis.

Taken together, the experiments in this study have established an EC/SMC coculture system as an in vitro representation of the physiological assembly of a normal blood vessel that offers a unique experimental system for the analysis of paracrine interactions of EC and SMC. We have applied the coculture model toward an analysis of factors that control the quiescent EC phenotype to demonstrate that SMC regulate EC quiescence and control the responsiveness to angiogenic cytokines such as VEGF. Further analysis of the observations in this study will be critical to understanding the interplay of cellular and molecular regulators of blood vessel assembly, maintenance, and maturation. The versatility of the coculture model also suggests that it may be a powerful tool toward the analysis of other EC and SMC interactions that are critical regulators not just during vascular morphogenesis, but also in pathological processes such as restenosis and atherosclerosis.


   ACKNOWLEDGMENTS
 
The authors would like to acknowledge the excellent technical assistance of Mrs. Renate Dietrich. We thank Dr. Franz-J. Kaup (DPZ, Göttingen, Germany) for assistance with the electron microscopic analyses. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SPP 1069 ‘Angiogenesis’: Au83/3–1).

Received for publication April 20, 2000. Revision received August 1, 2000.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Lindahl, P., Johansson, B. R., Leveen, P., Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277,242-245[Abstract/Free Full Text]
  2. Benjamin, L., Hemo, I., Keshet, E. (1998) A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125,1591-1598[Abstract]
  3. Benjamin, L. E., Keshet, E. (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94,8761-8766[Abstract/Free Full Text]
  4. Gale, N. W., Yancopoulos, G. D. (1999) Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13,1055-1066[Free Full Text]
  5. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science 277,48-50[Free Full Text]
  6. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., Yancopoulos, G. D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87,1171-1180[Medline]
  7. Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., Yancopoulos, G. D. (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science 282,468-471[Abstract/Free Full Text]
  8. Kim, I., Kim, H. G., So, J. N., Kim, J. H., Kwak, H. J., Koh, G. Y. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/akt signal transduction pathway. Circ. Res. 86,24-29[Abstract/Free Full Text]
  9. Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., Yancopoulos, G. D. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6,460-463[Medline]
  10. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., Yancopoulos, G. D. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277,55-60[Abstract/Free Full Text]
  11. Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmermanm, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., Barnathan, E. S., McCrae, K. R., Hug, B. A., Schmidt, A. M., Stern, D. M. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91,3527-3561[Free Full Text]
  12. Risau, W. (1995) Differentiation of endothelium. FASEB J 9,926-933[Abstract]
  13. Augustin, H. G., Kozian, D. H., Johnson, R. C. (1994) Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. BioEssays 16,901-906[Medline]
  14. Korff, T., Augustin, H. G. (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143,1341-1352[Abstract/Free Full Text]
  15. Korff, T., Augustin, H. G. (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell Sci. 112,3249-3258[Abstract]
  16. Fillinger, M. F., Sampson, L. N., Cronenwett, J. L., Powell, R. J., Wagner, R. J. (1997) Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J. Surg. Res. 67,169-178[Medline]
  17. Bonin, L. R., Damon, D. H. (1994) Vascular cell interactions modulate the expression of endothelin-1 and platelet-derived growth factor BB. Am. J. Physiol. 267,H1698-H1706[Abstract/Free Full Text]
  18. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126,3047-3055[Abstract]
  19. Alon, T., Hemo, I., Itin, A., Pe’er, J., Stone, J., Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1,1024-1028[Medline]
  20. Baumhueter, S., Dybdal, N., Kyle, C., Lasky, L. A. (1994) Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84,2554-2565[Abstract/Free Full Text]
  21. Fina, J., Molgard, M. V., Robertson, D., Bradley, N. J., Managhan, P. D., Sutherland, D. R., Baker, M. A., Graeves, M. F. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75,2417-2426[Abstract/Free Full Text]
  22. Delia, D., Lampugnani, M. G., Resnati, M., Dejana, E., Aiello, A., Fontanella, E., Soligo, D., Pierotti, M. A., Greaves, M. F. (1993) CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 81,1001-1008[Abstract/Free Full Text]
  23. Goede, V., Schmidt, T., Kimmina, S., Kozian, D., Augustin, H. G. (1998) Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78,1385-1394[Medline]
  24. Mandriota, S. J., Pepper, M. S. (1998) Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83,852-859[Abstract/Free Full Text]
  25. Powell, R. J., Bhargava, J., Basson, M. D., Sumpio, B. E. (1998) Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. Am. J. Physiol. 274,H642-H649[Abstract/Free Full Text]
  26. Hirschi, K. K., Rohovsky, S. A., D’Amore, P. A. (1998) PDGF, TGF-beta, and heterotypic cell–cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141,805-814[Abstract/Free Full Text]
  27. Axel, D. I., Riessen, R., Athanasiadis, A., Runge, H., Koveker, G., Karsch, K. R. (1997) Growth factor expression of human arterial smooth muscle cells and endothelial cells in a transfilter coculture system. J. Mol. Cell. Cardiol. 29,2967-2978[Medline]
  28. Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R., D’Amore, P. A. (1989) An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86,4544-4548[Abstract/Free Full Text]
  29. Sato, Y., Rifkin, D. B. (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109,309-315[Abstract/Free Full Text]
  30. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6,389-395[Medline]
  31. Risau, W. (1997) Mechanisms of angiogenesis. Nature (London) 386,671-674[Medline]
  32. Carmeliet, P. (2000) Molecular analysis of vascular development and disorders. Proc. Keystone Symp. Experimental and Clinical Regulation of Angiogenesis ,34
  33. Stratmann, A., Risau, W., Plate, K. H. (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153,1459-1466[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
N. E. Banziger-Tobler, C. Halin, K. Kajiya, and M. Detmar
Growth Hormone Promotes Lymphangiogenesis
Am. J. Pathol., August 1, 2008; 173(2): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Korff, J. Braun, D. Pfaff, H. G. Augustin, and M. Hecker
Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment
Blood, July 1, 2008; 112(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, E. Beaulieu, D. Labbe, V. Bedard, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling
Carcinogenesis, May 1, 2008; 29(5): 1033 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. S.N. Shim, I. A.W. Ho, and P. E.H. Wong
Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis
Mol. Cancer Res., July 1, 2007; 5(7): 655 - 665.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I. Yana, H. Sagara, S. Takaki, K. Takatsu, K. Nakamura, K. Nakao, M. Katsuki, S.-i. Taniguchi, T. Aoki, H. Sato, et al.
Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells
J. Cell Sci., May 1, 2007; 120(9): 1607 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Kasper, N. Dankert, J. Tuischer, M. Hoeft, T. Gaber, J. D. Glaeser, D. Zander, M. Tschirschmann, M. Thompson, G. Matziolis, et al.
Mesenchymal Stem Cells Regulate Angiogenesis According to Their Mechanical Environment
Stem Cells, April 1, 2007; 25(4): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Christov, F. Chretien, R. Abou-Khalil, G. Bassez, G. Vallet, F.-J. Authier, Y. Bassaglia, V. Shinin, S. Tajbakhsh, B. Chazaud, et al.
Muscle Satellite Cells and Endothelial Cells: Close Neighbors and Privileged Partners
Mol. Biol. Cell, April 1, 2007; 18(4): 1397 - 1409.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. Shraga-Heled, O. Kessler, C. Prahst, J. Kroll, H. Augustin, and G. Neufeld
Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor
FASEB J, March 1, 2007; 21(3): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Li, M. Petrimpol, K. D. Molle, M. N. Hall, E. J. Battegay, and R. Humar
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Circ. Res., January 5, 2007; 100(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Lederle, H.-J. Stark, M. Skobe, N. E. Fusenig, and M. M. Mueller
Platelet-Derived Growth Factor-BB Controls Epithelial Tumor Phenotype by Differential Growth Factor Regulation in Stromal Cells
Am. J. Pathol., November 1, 2006; 169(5): 1767 - 1783.
[Abstract]